July 2026
Core topics in this month’s edition include:
- Unique Pharmaceutical Laboratories – Recall of cetirizine tablet
- Jideytro™ (zidesamtinib) – New orphan drug approval
- Nuedexta® (dextromethorphan/quinidine sulfate) – First-time generic
- Rezzayo™ (rezafungin) – Expanded indication